Page last updated: 2024-08-23

dexchlorpheniramine and Cancer of Skin

dexchlorpheniramine has been researched along with Cancer of Skin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chosidow, O; Ingen-Housz-Oro, S; Ortonne, N1
Avril, MF; Brunet-Possenti, F; Dupin, N; Franck, N; Jacobelli, S; Tamburini, J1

Reviews

1 review(s) available for dexchlorpheniramine and Cancer of Skin

ArticleYear
Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
    Dermatology (Basel, Switzerland), 2011, Volume: 223, Issue:3

    Topics: Acetaminophen; Adult; Anti-Allergic Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Chlorpheniramine; Drug Therapy, Combination; Edema; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Methylprednisolone; Rituximab; Skin Neoplasms

2011

Other Studies

1 other study(ies) available for dexchlorpheniramine and Cancer of Skin

ArticleYear
Rituximab-related urticarial reaction overlying primary cutaneous follicle centre lymphoma: histological appearance and pathophysiological hypotheses.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:7

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Chlorpheniramine; Histamine H1 Antagonists; Humans; Infusions, Intravenous; Lymphoma, Follicular; Male; Mast Cells; Rituximab; Skin; Skin Neoplasms; Treatment Outcome; Urticaria

2014